NCT01849081
撤回
不适用
Evaluating the Efficacy of CPAP Therapy for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- Non-alcoholic Fatty Liver Disease
- 发起方
- Massachusetts General Hospital
- 试验地点
- 1
- 主要终点
- Steatosis by MRS
- 状态
- 撤回
- 最后更新
- 5年前
概览
简要总结
We are doing this research study to evaluate whether continuous positive airway pressure (CPAP), a treatment for sleep apnea, will also help treat fatty liver disease. Sleep apnea is a disease where a person has interruptions in their breathing while they are sleep. This can lead to low oxygen levels in the blood. CPAP is a mask that delivers oxygen at high pressure to the lungs to prevent a decrease in blood oxygen levels. CPAP is a known treatment for sleep apnea.
研究者
Kathleen E Corey
Instructor in Medicine
Massachusetts General Hospital
入排标准
入选标准
- •Adults 18 years of age or older with a previous liver biopsy showing NASH and at least grade 2 steatosis
- •Obstructive sleep apnea diagnosed by sleep study.
排除标准
- •Other causes of chronic liver disease
- •cirrhosis
- •less than 33% steatosis identified on magnetic resonance spectroscopy (MRS)
- •Alcohol use \>2 units per day for women or \>3 units per day for men
- •Intolerance to or refusal of CPAP therapy
- •overnight desaturation (more than 10% of the sleep time with oxygen desaturation below 85%)
- •underlying sever sleepiness (Epworth scale more than 15)
- •uncontrolled hypertension
- •Severe heart failure (ejection fracture less than 30%)
- •cardiac arrhythmias (atrial fibrillation or history of ventricular tachycardia)
结局指标
主要结局
Steatosis by MRS
时间窗: 12 weeks
Subjects will undergo baseline and 12 week magnetic resonance spectroscopy to assess the impact of CPAP or diet on fatty liver.
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Efficacy of CPAP Treatment on Blood Pressure of Resistant Hypertension Patients With Obstructive Sleep Apnea SyndromeObstructive Sleep Apnea SyndromeResistant HypertensionNCT01508754Universidade Federal do Rio de Janeiro125
已完成
不适用
Effects of Continuous Positive Airway Pressure (CPAP) Treatment on Glucose Control in Patients With Type 2 DiabetesObstructive Sleep ApneaType 2 DiabetesNCT01136785University of Chicago22
Unknown
4 期
CPAP in Liver TransplantHypoxemiaNCT00510770University of Turin, Italy80
已完成
不适用
CPAP/PSV Preoxygenation in Obese PatientsObesityAnaesthesiaNCT01780571Karolinska Institutet44
已完成
不适用
Assessment of the Effect of PAP on Energy and Vitality in Mild OSA Patients: The Merge StudyObstructive Sleep ApneaNCT02699463ResMed301